The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rotin D.L.

Moscow Clinical Scientific and Practical Center of Moscow Healthcare Department, Moscow, Russia

Clinico-morphological and molecular-biological aspects of cerebral metastases development

Authors:

Rotin D.L.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2012;76(2): 70‑76

Read: 4913 times

Contact the author
Table of contents

CLINICO-MORPHOLOGICAL AND MOLECULAR-BIOLOGICAL ASPECTS OF CEREBRAL METASTASES DEVELOPMENT
CLINICO-MORPHOLOGICAL AND MOLECULAR-BIOLOGICAL ASPECTS OF CEREBRAL METASTASES DEVELOPMENT

To cite this article:

Rotin DL. Clinico-morphological and molecular-biological aspects of cerebral metastases development. Burdenko's Journal of Neurosurgery. 2012;76(2):70‑76. (In Russ.)

Подписка 2025 Журнал «Вопросы нейрохирургии» имени Н.Н. Бурденко (Burdenko's Journal of Neurosurgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Ethmoid laby­rinth cancer with exte­nsion into the orbi­tal cavity. Russian Bulletin of Otorhinolaryngology. 2025;(4):119-122
New analgesics in onco­logy. Tafa­lgin employed as an alte­rnative to opioid analgesics. P.A. Herzen Journal of Onco­logy. 2025;(5):73-77
Tumor progression: a clinical case in the practice of a gene­ral practitioner. Russian Journal of Preventive Medi­cine. 2026;(3):98-101
Multiple foci of cere­bral ischemia in cancer patients with seco­ndary anti­phospholipid syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(3-2):84-89
Role of actin/actin-binding proteins in extracellular vesi­cles in mechanisms of tumor progression and deve­lopment of drug-induced poly­neuropathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(3):7-12
Packed red blood cell transfusions in perioperative period in patients with gastrointestinal mali­gnancies. Piro­gov Russian Journal of Surgery. 2026;(4):16-21
Outcomes of tongue & floor reco­nstruction after cancer rese­ction using the late­ral arm flap in Vietnam. Plastic Surgery and Aesthetic Medi­cine. 2026;(2):68-73
Abstract:

Keywords:

cerebral metastases
cancer
metastasizing

Authors:

Rotin D.L.

Moscow Clinical Scientific and Practical Center of Moscow Healthcare Department, Moscow, Russia

Close metadata

References:

  1. Arnold S.M., Young A.B., Munn R.K. et al. Expession of p53, bcl-2, E-cadherin, matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res 1999; 5 : 12: 4028-4033.
  2. Attwell S., Roskelly C., Dedhar S. The integrin-linked kinase (ILK) suppresses anoikis. Oncogene 2000; 19: 33: 3811-3815.
  3. Al-Shamy G., Sawaya R. Management of brain metastases: the indispensable role of surgery. J Neurooncol 2009; 92: 275-282.
  4. Barnholz-Sloan J.S., Sloan A.E., Lai P. et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system. J Clin Oncol 2004; 22: 14: 2865-2872.
  5. Barone T.A., Plunkett R.J., Hohmann P. et al. An experimental model of human leukemic meningitis in the nude rat. Blood 1997; 90: 1: 298-305.
  6. Bartelt S., Lutterbach J. Brain metastases in patients with cancer of unknown primary. J Neurooncol 2003; 64: 3: 249-253.
  7. Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 6: 401-410.
  8. Borsing L., Wong R., Hynes R.O. et al. Synergistic effects of L- and P- selectin in fascillating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA 2002; 99: 4: 2193-2198.
  9. Bouffet E., Doumi N., Thiesse P. et al. Brain metastases in children with solid tumors. Cancer 1997; 79: 2: 403-410.
  10. Breneman J.C., Steinmetz R., Smith A. et al. Frameless image-guided intracranial stereotactic radiosurgery: clinical outcomes for brain metastases. Int J Radiat Oncol Biol Phys 2009; 74: 3: 702-706.
  11. Braun S., Vogl F.D., Naume B. et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005; 353: 793-802.
  12. Brayton J., Qing Z., Hart M.N. et al. Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion. J Neuroimmunol 1998; 89: 1-2: 104-112.
  13. Brennan S.M., Gregory D.L., Stillie A. et al. Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 2010; 116: 4: 888-895.
  14. Bucholz R.D., Laycock K.A., Cuff L.E. CyberKnife stereotactic radiosurgery forintracranial neoplasms, with a focus on malignant tumors. Technol Cancer Res Treat 2010; 9: 6: 541-550.
  15. Camerer E., Quazi A.A., Duong D.N. et al. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004; 104: 2: 397-401.
  16. Cappuzzo F., Mazzoni F., Maestri A. et al. Medical treatment of brain metastases from solid tumours. Forum (Genova) 2004; 10: 2: 137-148.
  17. Cascino T.L., Leavengood J.M., Kemeny N. et al. Brain metastases from colon cancer. J Neurooncol 1983; 1: 203-209.
  18. Cavallaro U., Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta Rev Cancer 2001; 1552: 1: 39-45.
  19. Chambers A.F., Naumov G.N., Varghese H.J. et al. Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 2001; 10: 2: 243-255.
  20. Daryanni D., Plukker J.T., de Jong M.A. et al. Increased incidence of brain metastases in cutaneous head and neck melanoma. Melanoma Res 2005; 15: 2: 119-124.
  21. Davis F.G., McCarthy B., Jukich P. The descriptive epidemiology of brain tumors. Neuroimaging Clin N Am 1999; 9: 4: 581-594.
  22. Disibio G., French S.W. Mettastatic patterns of cancers: results from the large autopsy study. Arch Path Lab Med 2008; 132: 931-939.
  23. Douma S., Van L.T., Zevenhoven J. et al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430: 7003: 1034-1039.
  24. Ewing J. Metastasis. In: Neoplastic diseases: A Treatise on Tumours. Ed. J. Ewing. Philadelphia: W.B. Saunders 1940; 62-74.
  25. Felding-Habermann B., O'Toole T.E. et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 2001; 98: 4: 1853-1858.
  26. Fidler I.J. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 6: 453-458.
  27. Fidler I.J. The role of the organ microenvironment in brain metastasis. Semin Cancer Biol 2010.
  28. Fidler I.J., Yano S., Zhang R.D. et al. The seed and soil hypothesis; vascularisation and brain metastases. Lancet Oncol 2002; 3: 1: 53-57.
  29. Fogarty G.B., Tartaguia C. The utility of magnetic resonance imaging in the detection of brain metastases in the staging of cutaneous melanoma. Clin Oncol (R Coll Radiol) 2006; 18: 4: 360-362.
  30. Fogelholm R., Uutela T., Murros K. Epidemiology of the central nervous system neoplasms. A regional survey in Central Finland. Acta Neurol Scand 1984; 69: 129-136.
  31. Foldi M. The brain and the lymphatic system (I). Lymphology 1996; 29: 1: 1-9.
  32. Foldi M. The brain and the lymphatic system (II). Lymphology 1996; 29: 1: 10-14.
  33. Folgueras A.R., Pendas A.M., Sanchez L.M. et al. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004; 48: 5-6: 411-424.
  34. Follmore C.M., Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self renew. Breast Cancer Res 2008; 140: 62-73.
  35. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clower Memorial Award Lecture. Cancer Res 1986; 46: 467-473.
  36. Folkman J., Klagsbrun M. Angiogenic factors. Science 1987; 235: 4787: 442-447.
  37. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 5: 362-374.
  38. Gabos Z., Sinha R., Hanson J. et al. Prognostic significance of human epidermal growth factor receptor positivity for the development of the brain metastasis after newly diagnosed breast cancer. J Clin Oncol 2006; 20: 24: 36: 5658-5663.
  39. Gavrilovic I.T., Posner J.B. Brain metastases: epidemiology and pathophisiology. J Neurooncol 2005; 75: 1: 5-14.
  40. Gupta R.A., Shah N., Wang K.C. et al. Long-non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
  41. Guomundsson K.R. A survey of tumours of the central nervous system in Iceland during 10-year period 1954-1963. Acta Neurol Scand 1970; 46: 538-552.
  42. Harisi R., Kenessey I., Olah J.N. et al. Differential inhibition of single and cluster type tumor cell migration. Anticancer Res 2009; 29: 8: 2981-2985.
  43. Harabin-Slowinska M., Slowinski J., Konecki J. et al. Expression of adhesion molecule CD44 in metastatic brain tumors. Folia Neuropathol 1998; 36: 3: 179-184.
  44. Hay E.D. The mesenchimal cell, its role in the ebryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233: 3: 706-720.
  45. He B.P., Wang J.J., Zhang X. et al. Differential reactions of microglia to brain metastasis of lung cancer. Mol Med 2006; 12: 7-8: 161-170.
  46. Hedley B.D., Allan A.L., Chambers A.F. Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth. Future Oncol 2006; 2: 5: 627-641.
  47. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 2: 333-339.
  48. Hirshberg A., Leibovich P., Horowitz I. et al. Metastatic tumors to post-extraction sites. J Oral Maxillofac Surg 1993; 51: 12: 1334-1337.
  49. Hutter A., Schwetye K.E., Bierhals A.J. et al. Brain neoplasms: epidemiology, diagnosis, and prospects for cost-effective imaging. Neuroimaging Clin N Am 2003; 13: 2: 237-242.
  50. Hwang Close T.P., Grego J.M. et al. Predilection of brain metastasis and gray and white matter junction and vascular border zones. Cancer 1996; 77: 8: 1551-1555.
  51. Jaalinoja J., Herva R., Korpela M. et al. Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms. J Neurooncol 2000; 46: 1: 81-90.
  52. Jain R.K., Duda D.G., Willett C.G. et al. Biomarkers of response and resistance to antioangionetic therapy. Nat Rev Clin Oncol 2009; 6: 327-338.
  53. Johnston M., Zakharov A., Papaiconomou C. et al. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, nonhuman primates and other mammalian species. Cerebrospinal Fluid Res 2004; 1: 1: 2.
  54. Joyce J.A., Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 4: 239-252.
  55. Kamar F.G., Posner J.B. Brain metastases. Semin Neurol 2010; 30: 3: 217-235.
  56. Klein C.A., Blankenstein T.J., Schmidt-Kittler O. et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002; 360: 9334: 683-689.
  57. Knopf P.M., Cserr H.F., Nolan S.C. et al. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathol Appl Neurobiol 1995; 21: 175-180.
  58. Koh L., Zakharov A., Johnston M. Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption? Cerebrospinal Fluid Res 2005; 20: 2: 6.
  59. Kosir M.A., Wang W., Zukowski K.L. et al. Degradation of basement membrane by prostate tumor heparanase. J Surg Res 1999; 81: 1: 42-47.
  60. Larcos M.G., Maisey M.N. FDG-PET screening for cerebral metastases in patients with suspected malignancy. Nucl Med Commun 1996; 17: 3: 197-198.
  61. Larue L., Bellacosa A. Epithelial-mesenchimal transition in development and cancer: role of phosphatidylnositol 3' kinase/AKT pathways. Oncogene 2005; 24: 50: 7443-7454.
  62. Lassman A.B., DeAngelis L.M. Brain metastases. Neurol Clin 2003; 21: 1: 1-23.
  63. Lee J.M., Dedhar S., Kalluri R. et al. The epithelial-mesenchimal transition: new insights in signaling, development, and disease. J Cell Biol 2006; 172: 7: 973-981.
  64. Li G., Sathyamoorthy K., Herlyn M. N-cadherin-mediated intracellular interactions promote survival and migration of melanoma cells. Cancer Res 2001; 61: 9: 3819-3825.
  65. Luzzi K.J., MacDonald I.C., Schmidt E.E. et al. Multistep nature of metastatic inefficiency - Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 1998; 153: 3: 865-873.
  66. Machein M.R., Plate K.H. VEGF in brain tumors. J Neurooncol 2000; 50: 1-2: 109-120.
  67. Marusyk A., Polyak. et al. Tumor heterogeneity: causes and consequences. Biochim Biophis Acta 2010; 1805: 105-117.
  68. McDonald D.M., Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002; 62: 18: 5381-5385.
  69. Madajewicz S., Karakousis C., West C.R. et al. Malignant melanoma brain metastases: Review of Roswell Park Memorial Institute experience. Cancer 1984; 53: 11: 2550-2552.
  70. Moon K.S., Jung S., Lee M.C. et al. Metastatic glioblastoma in cervical lymph node after repeated craniotomies: report of a case with diagnosis by fine needle aspiration. J Korean Med Sci 2004; 19: 6: 911-914.
  71. Nathoo N., Chahlavi A., Bamett G.H. et al. Pathobiology of brain metastases. J Clin Pathol 2005; 58: 3: 237-242.
  72. Nielson S.L., Posner J.B. Brain metastasis localized to an area of infarction. J Neurooncol 1983; 1: 191-195.
  73. Nieman M.T., Prudoff R.S., Johnson K.R. et al. N-cadherin promotes motility in human breast cells regardless of their E-cadherin expression. J Cell Biol 1999; 147: 3: 631-644.
  74. Nishizaki T., Saito K., Jimi Y. et al. The role of cyberknife radiosurgery/ radiotherapy for brain metastases of multiple or large-size tumors. Minim Inv Neurosurg 2006; 49: 4: 203-209.
  75. Nussbaum E.S., Djalilian H.R., Cho K.H. et al. Brain metastases- Histology, multiplicity, surgery, and survival. Cancer 1996; 78: 8: 1781-1788.
  76. Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 1989; 8: 2: 98-101.
  77. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 6: 448-456.
  78. Pasqualini R., Arap W. Profiling the molecular diversity of blood vessels. Cold Spring Harb Symp Quant Biol 2002; 67: 223-225.
  79. Patchell R.A., Tibbs P.A., Walsh J.W. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322: 494-500.
  80. Percy A.K., Elveback L.R., Okazaki H. et al. Neoplasms of the central nervous system. Epidemiologic considerations. Neurology 1972; 22: 40-48.
  81. Pickern J.W., Lopez G., Tsukada Y. et al. Brain metastases: An autopsy study. Cancer Treat Symp 1983; 2: 295-313.
  82. Polyzidosis K.S., Miliaris G., Pavlidis N. Brain metastases of unknown primary: a diagnostic and therapeutic dilemma. Cancer Treat Rev 2005; 31: 4: 247-255.
  83. Poon R.T., Fan S.T., Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001; 19: 4: 1207-1225.
  84. Posner J.B., Chernik N.L. Intracranial metastases from systemic cancer. Adv Neurol 1978; 19; 575-587.
  85. Posner J.B. Neurologic complications of Cancer. Philadelphia: F.A. Davis 1995.
  86. Puduvalli V.K. Brain metastases: biology and the role of the brain microenviroment. Curr Oncol Rep 2001; 3: 6: 467-475.
  87. Schouten L.J., Rutten J., Huveneers H.A.M. et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94: 10: 2698-2705.
  88. Schulenburg A., Ulrich-Pur H., Thurner D. et al. Neoplastic stem cells: A novel therapeutic target in clinical oncology. Cancer 2006; 107: 10: 2512-2520.
  89. Seute T., Leffers P., Willmink J.T. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy. J Clin Oncol 2006; 243: 13: 2079-2083.
  90. Shojania K.G., Burton E.C., McDonald K.M. et al. Changes in rates of autopsy-detected diagnostic error over time: a systematic review. JAMA 2003; 289: 21: 2849-2856.
  91. Sleeman J., Steeg P.S. Cancer metastasis as a therapeutic target. Eur J Cancer 2010; 46: 7: 1177-1180.
  92. Steeg P.S., Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 2008; 5: 4: 206-219.
  93. Sugarbaker E.V. Cancer metastasis: a product of tumor-host interactions. Curr Probl Cancer 1979; 3: 7: 1-59.
  94. Tarin D., Price J.E., Kettlewell M.G. et al. Mechanisms of human tumor metasatasis studied in patients with peritonovenous shunts. Cancer Res 1984; 44: 8: 3584-3592.
  95. Tham Y.L., Sexton K., Kramer R. et al. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer 2006; 107: 4: 696-704.
  96. Trepel M., Pasqualini R., Arap W. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides. Methods Enzymol 2008; 445: 83-106.
  97. Valastyan S., Reinhardt F., Benaich N. A pleiotropically acting microRNA inhibits breast cancer metastasis. Cell 2009; 137; 1032-1046.
  98. Van Schil P.E., Hendriks J.M., Carp L., Lauwers P.R. Surgery for oligometastatic disease in non-small-cell lung cancer. Exp Rev Anticancer Ther 2008; 8: 12: 1931-1938.
  99. Walker A.E., Robbins M., Weinfield F.D. Epidemiology of brain tumors: The national survey of intracranial neoplasms. Neurology 1985; 35: 219-226.
  100. Weiss L. Comments on hematogenous metastatic patterns in human as revealed by autopsy. Clin Exp Metastasis 1992; 10: 191-199.
  101. Wyckoff J.B., Wang Y., Lin E.Y. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 2007; 67: 6: 2649-2656.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.